Skip to content
  • Monday, 1 June 2026
  • 1:37 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk Launches Oral Ozempic in the US, Revolutionizing Type 2 Diabetes and Cardiovascular Risk Management
Pharmaceutical R&D

Novo Nordisk Launches Oral Ozempic in the US, Revolutionizing Type 2 Diabetes and Cardiovascular Risk Management

Teuku Ryan May 4, 2026 0

The landscape of type 2 diabetes management and cardiovascular risk reduction in the United States has been significantly reshaped with…

Read More
Pharmaceutical R&D

Dulaglutide Shows Promise in Stabilizing Coronary Plaques, Revolutionizing Cardiovascular Protection Beyond Diabetes Management

Teuku Ryan Apr 1, 2026 0

The intricate relationship between Type 2 diabetes (T2D) and cardiovascular health has long been a focal point of medical research.…

Read More
This “rotten egg” brain gas could be the key to fighting Alzheimer’s diseaseLudwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous LeukemiaAtomic Roaming and the Hidden Drivers of Radiation Damage: Scientists Capture Real-Time Motion Before Molecular DecayScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Genomic Breakthrough Reveals the Explosive Pre-Clinical Growth and Evolutionary Timeline of Chronic Myeloid LeukemiaSingaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye DiseaseLilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?Brain Protein Menin Identified as Potential Master Regulator of Biological Aging and Cognitive Health
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Genomic Breakthrough Reveals the Explosive Pre-Clinical Growth and Evolutionary Timeline of Chronic Myeloid Leukemia
Dwi Wanna Jun 1, 2026
Biotech & Genetic Research
Singaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye Disease
Jia Lissa Jun 1, 2026
Laboratory Automation & Robotics
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Lana Keisha Jun 1, 2026
Neuroscience & Brain Research
Brain Protein Menin Identified as Potential Master Regulator of Biological Aging and Cognitive Health
Rifan Muazin Jun 1, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ